The new alchemy

Article Abstract:

There have been a number of mergers in the pharmaceutical industry, and a new, large merger is planned between Glaxo Wellcome's and SmithKline Beecham. There has been speculation that this merger will trigger a new wave of mergers. Mergers can lead to disruption, as well as loss of market share. Size can be a benefit when developing new drugs, but new deals in the industry may bring benefits from combining research activities using new genetic tecnology.

Industry Overview

---

Pills popping up

Article Abstract:

Trends affecting stocks in pharmaceutical companies and their impact on stock markets are examined in detail.

Securities and Commodity Exchanges, Security and commodity exchanges, Securities Exchanges, Stock-exchange, Stock exchanges

---

Beyond the behemoths

Article Abstract:

Consolidation in pharmaceuticals and biotech is being driven by a need to generate economies of scale and stay competitive. Pharmaceutical service companies allow companies to outsource segments of the pipeline process, reducing costs.

Research and Development in the Physical, Engineering, and Life Sciences, Genetic Engineering, Biotechnology industry, Biotechnology industries

Similar abstracts:

• Abstracts: Foot on the brake. Up we go again. Up again
• Abstracts: The war of the wires. Riding the storm. Wheels and wires
• Abstracts: Commanding depths. Always right? Centre-fold?
• Abstracts: A tale of two giants. Cold comfort farm. Under new management
• Abstracts: Goldman gets glory in record year. Goodwill hunting. Risky chasers

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.